Global Dermatology Workforce Reveals Deep Inequities: 175,633 Dermatologists Worldwide but Access Remains Poor in Lower‑Income Nations

Key Highlights
Introduction
How the Survey Mapped the Global Dermatology Workforce
The Numbers: Density, Totals, and What They Mean
Where Care Is Missing: Access and Subspecialty Shortfalls
Urban Concentration: Why Geography Exacerbates Inequity
Training Pipeline: Where New Dermatologists (Don’t) Come From
Non‑dermatologist Providers: Task‑Sharing and Upskilling
Teledermatology and Digital Tools: Scalable but Not a Panacea
Financing Access: Who Pays and What Works
Health System Barriers Beyond Workforce Numbers
Human Impact: Vignettes That Illustrate System Failures
Regional and Income‑Level Patterns: What Drives the Differences
Practical Steps for Countries Seeking Rapid Gains
Long‑Term Strategies: Building Sustainable Capacity
The Role of Professional Societies and International Collaboration
Monitoring Progress: Metrics That Matter
Research Gaps and Future Studies
Ethical and Equity Considerations
What the Survey Means for Patients and Clinicians
Governance, Accountability, and the Skin Observatory
Limitations of the Survey and Cautions for Interpretation
A Call to Action: Strategic Priorities for the Next Five Years
FAQ

Key Highlights

A multinational survey covering 158 countries found an average dermatologist density of 2.66 per 100,000 people and estimates a global workforce of approximately 175,633 dermatologists. Density ranges sharply by income: 0.37 per 100,000 in low‑income countries versus 5.05 in high‑income countries.
Forty‑two percent of responding countries described access to dermatological care as inadequate or extremely poor; subspecialty services, training programs, and distribution of clinicians are concentrated in wealthier, urban areas, leaving rural and low‑resource populations underserved.
Closing gaps will require coordinated actions: expand and fund training programs, decentralize services, scale teledermatology and task‑sharing, and redirect financing toward sustainable workforce development and service delivery in lower‑income settings.

Introduction

Skin conditions affect nearly half the global population at some point in their lives and contribute substantially to morbidity, disability, and health system burden. Despite this pervasive need, the global distribution of dermatological expertise remained poorly quantified until now. A multinational cross‑sectional survey spanning 194 World Health Organization member states and three additional geographic areas, conducted during 2024–2025, provides the most comprehensive picture to date of dermatologist numbers, distribution, training capacity, and perceived access to care.

Responses from 158 countries reveal a global workforce of roughly 175,633 dermatologists, concentrated in urban centers and high‑income settings. The data expose stark inequities: countries with the fewest specialists report the worst access to basic and subspecialty dermatologic care, and one in five nations lack any local dermatology training program. Those gaps shape patient pathways, clinical outcomes, and health system priorities. The findings demand policy responses that go beyond short‑term fixes and toward sustainable systems strengthening.

The following analysis synthesizes the survey’s core findings, examines the implications for patients and health systems, and offers evidence‑informed paths for governments, funders, and professional bodies to expand access to skin health.

How the Survey Mapped the Global Dermatology Workforce

The survey targeted country‑level leaders, professional organizations, and stakeholders with knowledge of national dermatology capacity. Primary outcomes were dermatologist density per 100,000 population and the total number of dermatologists; secondary outcomes captured the presence and density of training programs, workforce distribution between urban and rural settings, perceived access to dermatology care (including subspecialty services), and relevant health system characteristics. Descriptive statistics and nonparametric tests compared outcomes across World Bank Income levels and WHO regions.

Key methodological strengths: breadth (responses from 158 of 197 areas) and a multi‑metric approach that combined objective workforce counts with subjective access assessments. The survey offers both a snapshot of the current staffing landscape and indicators of where bottlenecks in training and service delivery occur. It also provides a baseline against which future investments and reforms can be measured.

Limitations inherent to global surveys apply: some countries provided administrative counts while others relied on estimates, and differences in how dermatologists are certified or practice across systems complicate direct comparisons. Nevertheless, the aggregate estimates and consistent patterns across income strata and regions yield strong signals about global inequality in dermatologic care.

The Numbers: Density, Totals, and What They Mean

Two figures capture the scale and skew of the workforce: mean dermatologist density and the estimated global total.

Mean dermatologist density: 2.66 dermatologists per 100,000 population.
Estimated global total: 175,633 dermatologists (95% confidence interval: 173,598–177,668).

These averages mask large variation. The survey reports a mean density of 0.37 per 100,000 in low‑income countries (LICs) compared with 5.05 per 100,000 in high‑income countries (HICs). That represents more than a tenfold difference in specialist availability by income level. Even within higher‑income strata, distribution matters: urban centers routinely host a disproportionate share of clinicians.

Why density matters: dermatologist availability strongly influences timeliness of diagnosis, management of chronic inflammatory diseases (such as psoriasis and eczema), recognition of skin cancers, and appropriate treatment for infectious dermatoses common in some climates. A density at the LIC average — fewer than one specialist per 250,000 people — makes it improbable that routine dermatologic services will be locally accessible, let alone dermatopathology, pediatric dermatology, or surgical dermatology.

The survey’s global total — roughly 175,600 dermatologists — represents the collective capacity available today. That number is a foundation for workforce planning: it helps estimate how many additional specialists would be required to match densities seen in wealthier countries and, more importantly, how many clinicians and complementary strategies are needed to meet population needs in lower‑resource settings.

Where Care Is Missing: Access and Subspecialty Shortfalls

Access was measured not only by headcounts but by respondents’ perceptions of how well populations could obtain dermatologic care. Forty‑two percent of countries rated access as inadequate or extremely poor. Access deficits were not limited to general dermatology; subspecialty services showed consistent, statistically significant disparities across income levels for pediatric dermatology, dermatologic surgery, and dermatopathology (p < 0.001).

Consequences of subspecialty shortages:

Pediatric dermatology shortages leave infants and children vulnerable to misdiagnosis, delayed treatment for congenital or inflammatory conditions, and inadequate management of common childhood skin infections.
Limited dermatologic surgery capacity affects removal of suspicious lesions and treatment of skin cancers. Where access is lacking, referrals to tertiary centers may be delayed or impossible.
Dermatopathology deficits impair diagnostic accuracy. Without biopsy interpretation, clinicians must often treat empirically or send samples abroad, introducing delays and additional costs.

The shortfalls are not academic. For a patient with a rapidly growing pigmented lesion in a rural district with no local dermatologist or dermatopathology service, the delay in diagnosis could mean the difference between early excision and advanced melanoma with far worse prognosis. For children with severe atopic dermatitis, lack of specialized care can translate into prolonged suffering, sleep disturbance, and family economic strain.

Urban Concentration: Why Geography Exacerbates Inequity

Seventy‑nine percent of dermatologists reported practicing primarily in urban centers. The urban tilt of the workforce compounds shortages in low‑resource countries, where a majority of the population may live in rural or peri‑urban areas. A patient living several hours from the nearest city faces transport costs, loss of income, and logistical barriers that deter specialist visits. That geography drives downstream effects: common conditions go untreated longer, outbreaks of scabies or fungal disease persist, and skin cancers present at later stages.

Concentration in capitals and major cities reflects economic incentives and professional preferences: higher incomes, stronger private sectors, greater access to diagnostic facilities, and more opportunities for subspecialty practice and continuing professional development. That rational distribution for individual clinicians creates a public health problem that requires deliberate policy levers to correct.

Policy levers to encourage geographic redistribution include:

Financial incentives: rural hardship pay, loan forgiveness, and targeted salary supplements.
Career incentives: fast‑track promotion, academic recognition, or protected time for research for clinicians who practice in underserved areas.
Professional support: teleconsultation networks that reduce professional isolation and connect rural clinicians with mentors in tertiary centers.
Infrastructure: ensuring rural facilities have the equipment and supply chains needed for dermatologic procedures and managing chronic skin conditions.

Implementing and sustaining such levers requires political will and funding commitments that align with broader efforts to strengthen primary and secondary health services.

Training Pipeline: Where New Dermatologists (Don’t) Come From

Twenty‑one percent of countries surveyed lack any dermatology training program. Training density varies markedly by income level (p < 0.001), creating a pipeline problem: countries without local training programs must rely on overseas training, which often results in permanent emigration of trainees, or on non‑specialist practitioners to manage skin disease without specialist supervision.

Training gaps have ripple effects:

Countries with no training capacity cannot scale the workforce locally without long‑term investment.
Reliance on overseas training introduces brain drain. Trainees who study in high‑income countries frequently remain there, attracted by higher salaries and better working conditions.
Absence of local training inhibits development of context‑appropriate clinical guidelines, research capacity, and systems for subspecialty care.

Addressing the training gap requires blended strategies. Short‑term measures can include visiting faculty exchanges, modular courses tailored to local disease burdens, and regionally accredited fellowships that incentivize return. Long‑term solutions must invest in national postgraduate programs, strengthen medical school curricula to include dermatology, and pair investments in training with retention strategies such as competitive compensation and career development opportunities.

Non‑dermatologist Providers: Task‑Sharing and Upskilling

With limited numbers of specialists, many countries rely on non‑dermatologist healthcare workers — general practitioners, nurses, community health workers, and physician assistants — to provide most skin care. The survey highlights that non‑dermatologist providers already shoulder a substantial share of the burden.

Task‑sharing is a pragmatic response, but it must be structured. Effective programs combine concise, competency‑based training with decision support, referral pathways, and supervision. Examples of effective elements:

Algorithmic management for common conditions (scabies, tinea, uncomplicated dermatitis).
Point‑of‑care diagnostic aids, such as dermoscopy training for broad lesion triage.
Teleconsultation bridges that allow primary care clinicians to obtain rapid specialist advice for complex cases.
Continuing education modules integrated into national primary care training programs.

Upskilling frontline providers expands access rapidly and at lower cost than training large numbers of specialists. That strategy is particularly valuable for routine and infectious skin diseases that account for much of the outpatient dermatology workload in many settings. For complex cases and subspecialty needs, a tiered system that routes referrals to regional specialists or teledermatology is essential.

Teledermatology and Digital Tools: Scalable but Not a Panacea

Digital technologies can mitigate geographic barriers by enabling remote triage, second opinions, and asynchronous consultations. Teledermatology has a strong evidence base for diagnostic concordance with in‑person evaluation for many conditions, particularly when high‑quality images accompany clinical history.

Key considerations for scaling teledermatology:

Image quality matters. Training clinicians and community health workers on standardized photography improves diagnostic yield.
Integration into health systems is essential. Teleconsultation must be available within reimbursement frameworks or donor‑supported models, with clear referral pathways for in‑person care when indicated.
Data security and patient consent require regulatory frameworks that protect privacy while enabling care.
Telemedicine does not replace the need for procedures, biopsies, or medication supply chains; it must be part of a broader service package.

Teledermatology programs can extend specialist reach at modest incremental cost, but they require investments in digital infrastructure, clinician training, and governance to achieve lasting impact.

Financing Access: Who Pays and What Works

The survey was funded through a collaboration between the International League of Dermatological Societies and L’Oréal Dermatological Beauty, highlighting the role that professional societies and private partners can play in global dermatology initiatives. Sustainable financing to address workforce shortages and service gaps will require diversified approaches.

Potential financing pathways:

Government budget allocations aligned with universal health coverage commitments, ensuring dermatologic services are included in essential benefits packages.
Development assistance and global health grants targeted at capacity building for training programs, telehealth platforms, and supply chains for dermatologic medications.
Public–private partnerships that leverage private sector logistics, training expertise, and funding while ensuring public accountability and equitable access.
Philanthropic investments in scholarships for trainees from underserved countries, support for regional training hubs, and seed funding for teledermatology networks.

Any financing approach must prioritize sustainability, avoid creating parallel systems that fragment care, and ensure that investments build local capacity rather than perpetuating dependence on external actors.

Health System Barriers Beyond Workforce Numbers

Quantifying dermatologists is necessary but not sufficient to understand access. Other health system features determine whether specialists translate into care for patients.

Supply chain and medication access: Effective dermatologic care often depends on access to topical therapies, antifungals, antiparasitics, biologics, or surgical supplies. Stockouts and cost barriers negate the benefits of specialist consultations.

Referral systems and primary care integration: Weak referral pathways create bottlenecks, with specialists overwhelmed by cases that could be managed at lower levels of care. Clear protocols and capacity building at primary care level reduce inappropriate specialist demand.

Regulatory and licensing issues: In some settings, scope‑of‑practice rules limit the ability of non‑dermatologists to perform certain diagnostics or procedures, even when trained.

Data systems and surveillance: Lack of routine data on skin disease burdens and outcomes reduces the visibility of skin health needs in national planning and makes it harder to allocate resources rationally.

Addressing these systemic barriers calls for cross‑sectoral reforms that align workforce investments with supply chain improvements, regulatory flexibility, and better use of data for planning.

Human Impact: Vignettes That Illustrate System Failures

The statistics translate into real hardship for patients and families. The following hypothetical vignettes illustrate common scenarios reported anecdotally by clinicians in low‑resource settings.

A five‑year‑old child in a rural district develops severe scabies complicated by secondary bacterial infection. The nearest dermatologist is a six‑hour bus ride away. Local health workers treat with topical permethrin when available, but supply is intermittent. Repeated infections lead to anemia and school absenteeism.
An adult in a peri‑urban area notices a rapidly expanding pigmented lesion. The primary care clinician, unsure whether biopsy is needed, hesitates because the local pathology service is months behind. By the time the lesion receives specialist review, it has advanced beyond curative options.
A middle‑aged patient with recalcitrant psoriasis in a lower‑income country has no access to systemic immunomodulators or biologic therapies available in wealthier settings. Symptom control is partial, work productivity declines, and comorbid depression goes untreated.

These vignettes capture how workforce shortages, supply constraints, and fragmented services converge to worsen outcomes. They also emphasize where targeted interventions — community treatment campaigns, teletriage, subsidized medicines, or regional training hubs — can produce tangible improvements.

Regional and Income‑Level Patterns: What Drives the Differences

The survey found consistent patterns: lower dermatologist density, fewer training programs, worse access to subspecialty care, and greater rural shortages in lower‑income countries. Multiple drivers explain these patterns:

Economic incentives: Specialists follow where reimbursement and private practice opportunities exist.
Education systems: Establishing postgraduate training requires faculty, clinical volume, and resources. Countries without medical school capacity struggle to launch specialty programs.
Migration: Health worker migration to higher‑income countries drains local stocks of trained clinicians.
Health priorities: Where infectious disease burdens or other competing health priorities consume limited budgets, dermatology may receive lower priority.
Market dynamics: Pharmaceutical and device markets that support dermatologic services are smaller in lower‑income settings, limiting investment in specialty infrastructure.

Understanding these drivers is critical to designing interventions that are feasible and politically acceptable in each context.

Practical Steps for Countries Seeking Rapid Gains

Some interventions can produce relatively fast improvements in access:

Establish standardized primary care dermatology protocols for common conditions and train primary care workers to manage them.
Launch teledermatology pilots focusing on high‑volume, easily triaged conditions, with quality metrics and pathways for escalation.
Create regional training hubs that serve multiple neighboring countries and offer short fellowships and exchange opportunities.
Invest in essential dermatologic medicines and ensure they are listed on national essential medicines lists with procurement guarantees.
Use incentives and bonded scholarships to encourage trainees to return and practice in underserved areas.

These steps can be implemented with modest investments compared with the time and cost required to expand the specialist workforce through full postgraduate training alone.

Long‑Term Strategies: Building Sustainable Capacity

Long‑term solutions must address training, retention, financing, and integration.

Scale national postgraduate dermatology programs with curricula tailored to local burden of disease, including training in infectious dermatoses common in tropical climates.
Strengthen career pathways and professional development to retain specialists, including protected time for research and teaching to build local faculty.
Integrate dermatology into universal health coverage packages, ensuring financial protection for patients and predictable funding for services.
Support research networks and registries to generate context‑specific evidence that informs training and policy.
Foster regional collaboration between professional societies to standardize training, accreditation, and reciprocity of qualifications.

These strategies require multi‑year commitments and partnership across governments, international organizations, academic institutions, and private sector actors.

The Role of Professional Societies and International Collaboration

Professional societies, like the International League of Dermatological Societies (ILDS), play a pivotal role in coordinating global efforts. Societies can:

Set standards for training and certification.
Facilitate faculty exchanges and mentorship programs.
Help deploy rapid response teams during shortages.
Advocate to governments for inclusion of dermatology in national health priorities.

International collaboration reduces duplication, creates economies of scale for training programs, and fosters shared platforms such as the Skin Observatory referenced in the survey, which will host a public data explorer to support planning and accountability.

Monitoring Progress: Metrics That Matter

Tracking investments and outcomes requires measurable indicators. Useful metrics include:

Dermatologist density per 100,000 population, tracked annually.
Percentage of population within a defined travel time (e.g., two hours) to a dermatologist or dermatology clinic.
Number and geographic distribution of accredited dermatology training programs.
Wait times for initial dermatology consultation and for biopsy/dermatopathology results.
Availability and stockout frequency of essential dermatologic medicines.
Proportion of primary care clinicians trained in standardized dermatology protocols.

A combination of workforce, access, and service delivery metrics will allow policymakers to measure progress and target interventions where they yield the greatest benefit.

Research Gaps and Future Studies

The survey establishes baseline data but raises questions that require further research:

What is the relationship between dermatologist density and patient outcomes for specific conditions (e.g., time to melanoma diagnosis, control of severe atopic dermatitis)?
Which task‑sharing models produce the best balance of safety, quality, and cost‑effectiveness in different contexts?
How do financing models (public coverage, private insurance, out‑of‑pocket) affect access to dermatologic care and medicines?
What incentives most effectively promote rural practice and reduce migration of specialists?

Answering these questions will guide targeted, evidence‑driven investments.

Ethical and Equity Considerations

Workforce policies must prioritize equity. Policies that increase overall specialist numbers but leave rural and marginalized populations behind will perpetuate disparities. Equity‑oriented strategies include targeted scholarships for trainees from underserved regions with return‑of‑service obligations, explicit rural recruitment goals, and community‑based training rotations that orient clinicians to local needs.

Ethical concerns also arise with telemedicine and cross‑border training. Consent, data protection, and reciprocity in faculty exchanges must be governed by clear agreements that respect local autonomy and ensure local benefit.

What the Survey Means for Patients and Clinicians

For patients, the survey confirms what many already experience: access to specialist skin care depends heavily on where they live and their country’s resources. For clinicians, particularly those in primary care and community settings, the findings validate their central role in managing skin disease and signal opportunities for upskilling and integration into broader skin health systems.

For policymakers, the data provide a compelling case to include dermatologic services in health system strengthening plans and universal health coverage agendas. For donors and global health actors, the survey identifies high‑impact entry points: training support, telemedicine scale‑up, regional centers of excellence, and supply chain investments.

Governance, Accountability, and the Skin Observatory

The survey team plans a public data explorer hosted at skinobservatory.org. Transparent, accessible data empower civil society, professional societies, and governments to hold stakeholders accountable for progress. Government commitment can be bolstered when data demonstrate clear inequities and concrete gains from targeted interventions.

Effective governance requires multi‑stakeholder platforms where ministries of health, professional societies, donor agencies, and community representatives co‑design priorities. Accountability mechanisms should include publicly available progress reports and third‑party evaluations of key initiatives.

Limitations of the Survey and Cautions for Interpretation

Interpretation of the findings should consider several caveats:

Partial response: The survey captured data from 158 of 197 WHO member states and areas. Non‑responding countries may differ systematically.
Variability in definitions: Some countries define dermatologists differently (e.g., by certification or practice scope), which can affect counts.
Self‑reported access measures: Perceptions of access incorporate subjective elements and may not reflect objective service availability.
Cross‑sectional design: The survey reflects a point in time; workforce numbers and distribution can change rapidly with policy interventions or migration.

Despite these limitations, the consistency of patterns across income groups and regions supports the validity of the core conclusions about global disparities.

A Call to Action: Strategic Priorities for the Next Five Years

Rapid improvements in skin health access are achievable with focused, coordinated action. Priorities for the coming five years should include:

Expand training capacity through regional hubs and faculty development.
Deploy teledermatology as an integrated component of national health systems with clear referral pathways.
Invest in primary care upskilling and algorithmic management for common skin conditions.
Institute financial and career incentives to redistribute specialists to underserved areas.
Ensure essential medicines and supplies for dermatologic care are consistently available and affordable.
Strengthen data systems and public reporting through platforms such as the Skin Observatory.

These steps require alignment between ministries, professional societies, donors, and communities. When implemented together, they will expand access, strengthen local capacity, and improve health outcomes for millions affected by skin disease.

FAQ

Q: What does "dermatologist density per 100,000" mean? A: Dermatologist density is the number of practicing dermatologists standardized to a population of 100,000 people. It allows comparisons between countries of different sizes by indicating how many specialists are available relative to population.

Q: How many dermatologists are there globally? A: The survey estimates approximately 175,633 dermatologists worldwide (95% confidence interval: 173,598–177,668). That total masks substantial variation in distribution and access.

Q: Why are dermatologist numbers so low in some countries? A: Low numbers reflect multiple factors: lack of local training programs, migration of trainees to higher‑income countries, limited financial incentives for specialist practice, and health system priorities that allocate scarce resources elsewhere.

Q: Do all countries have dermatology training programs? A: No. Twenty‑one percent of countries surveyed reported having no dermatology training program. Training density varies strongly by income level.

Q: Can non‑dermatologist clinicians effectively manage skin conditions? A: With appropriate training, supervision, and referral pathways, non‑dermatologist clinicians can manage many common skin conditions safely and effectively. Structured task‑sharing and clear protocols are essential to maintain quality of care.

Q: Is teledermatology a viable solution for underserved areas? A: Teledermatology is an effective tool to expand access, particularly for initial triage and management guidance. Its success depends on image quality, digital infrastructure, integration into health systems, and availability of follow‑up services for procedures or complex cases.

Q: What immediate actions can governments take to improve access? A: Governments can prioritize dermatology within universal health coverage, fund training and retention programs, include essential dermatologic medicines in national formularies, and support telehealth and primary care capacity building.

Q: Where can I access the survey data? A: A public data explorer will be available at www.skinobservatory.org. Additional data can be requested from the corresponding author of the survey.

Q: Who funded the survey and declared interests? A: The study was funded by the International League of Dermatological Societies (ILDS) in collaboration with L’Oréal Dermatological Beauty. Conflicts of interest were disclosed by the authors in the original report.

Q: How can clinicians and professional societies help address these gaps? A: Clinicians can participate in teaching and mentorship, support teleconsultation networks, advocate for inclusion of dermatology in national health plans, and collaborate on regional training initiatives that build local capacity.

Q: Will increasing the number of dermatologists alone solve access problems? A: Increasing specialist numbers is necessary but not sufficient. Improving access requires concurrent investments in training pipelines, rural incentives, integration with primary care, supply chains for medicines, and data systems to measure progress.

Q: What research is needed next? A: Priority research includes evaluating the impact of different task‑sharing models, determining cost‑effectiveness of teledermatology deployments in various settings, and assessing the relationship between dermatologist density and clinical outcomes for priority skin conditions.

Q: How soon can improvements be expected? A: Some interventions, such as primary care training and teledermatology pilots, can expand access within months to a few years. Scaling training programs and shifting workforce distribution are multi‑year efforts that require sustained commitment.

Q: How can donors best support global dermatology capacity building? A: Donors should prioritize investments that build local training capacity, support integrated telehealth solutions, finance essential medicines and supply chains, and fund evidence generation to guide scalable models.

Q: Can individuals contribute to improving skin health equity? A: Yes. Clinicians can volunteer in training programs or teleconsultation networks. Academic institutions can form partnerships with regional centers. Patients and civil society can advocate for inclusion of dermatologic care in national health benefits.